AbbVie profit beats on better-than-expected Botox sales
AbbVie has today beaten Wall Street estimates for fourth-quarter profit today, helped by a smaller-than-expected decline in sales of its blockbuster drug, Humira, and strong demand for Botox amid stiff competition.
Business
• 02 Feb 24
